Search
Close this search box.

How pharmaceutical organizations can strengthen their security posture and make it more challenging for adversaries to carry out attacks?

A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN

By Pritam Shah, Global Practice Head – OT Security, Inspira Enterprise

As the pharmaceutical sector embraces digital transformation with a focus on smart manufacturing, digital supply chains, phase IV trials, and customer value, cybersecurity and OT (Operational Technology) security take center stage.  Pharma organizations, housing sensitive patient data, clinical trials, patented drugs, and technological advancements are enticing targets for cybercriminals, as seen in recent attacks on Sun Pharma and Granules India.  Such incidents globally impact public health and national security.

OT devices in pharma, like in other sectors, initially were not built with security in mind and relied on air gaps for separation.  Today’s technological advancements blur the line between OT and IT, offering productivity, efficiency, and faster time to market, but unfortunately introducing high-security risks.  Among the many challenges faced by pharma organizations, IT/OT convergence and legacy OT systems are significant concerns.

Threat actors are increasingly targeting the convergence point of IT and OT driving the need for a unified defense strategy to bridge the gap between IT and OT security.

Picture of Anoop Ravindra

Anoop Ravindra

Leave a Replay

Sign up for our Newsletter

Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit

News in spotlight